University of Maryland, USA, University of Washington, USA, Nova Southeastern University, USA, Temple University, USA;
Prof. Dr. Jon Suzuki holds Clinical Professorships at the University of Maryland, the University of Washington, and Nova Southeastern University. He is Professor Emeritus of Microbiology and Immunology (School of Medicine) and Professor Emeritus of Periodontology and Oral Implantology (School of Dentistry) at Temple University, Philadelphia, PA., USA. He is also a Special Government Agent for the Food and Drug Administration (FDA) Dental Products Advisory Panel. Dr. Suzuki received his D.D.S. from Loyola University of Chicago and his Ph.D. in Microbiology from the Illinois Institute of Technology. He completed an N.I.H. Fellowship in Immunology at the University of Washington, and a Clinical Certificate in Periodontics at the University of Maryland.

Department of Pharmacy, University of Salerno, Italy;
Dr. Sorrentino's research focuses on the understanding and analysis of inflammation pathways and immune cells involved in acute and chronic lung pathologies.

Department of Medicine, Surgery and Health Sciences, University of Trieste, Italy;
Active in the fields of forensic pathology and toxicology, bioethics and clinical risk management, and medical liability. Research interests include forensic autopsy technique, forensic pathology, forensic toxicology, cardiopathology, sudden death, and clinical risk management. Expert witness for the Italian Courts. Manager of the Registry of Sudden Cardiac Death in Friuli-Venezia Giulia, Italy.

Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Italy;
Dr. D'Alessandro started her research in translational medicine for lung diseases with the project "Interaction between solid lipid nanoparticles and respiratory epithelial cells: in vitro study of uptake and biocompatibility". Since then, D'Alessandro has researched novel biomarkers of diffuse lung diseases, asthma, COVID-19, and lung transplantation. Her research focuses on the immune system in different biological matrices - including bronchoalveolar lavage of fibrotic interstitial lung disease patients and the validation of novel biomarkers such as the Krebs von den Lungen-6 and extracellular vesicles.

Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Italy;
Dr. Gangi is a PhD candidate in the Respiratory Diseases Unit at the University of Siena. Her project focuses on the analysis of prognostic and diagnostic biomarkers in fibrotic interstitial lung diseases, COVID-19, and lung transplants. Dr. Gangi has developed a good knowledge base on cell culture, flow cytometry analysis, and chemiluminescent methods. She worked on the development of a novel fibroblast cell line isolated by bronchoalveolar lavage of IPF patients. She has authored/coauthored 17 research documents and given lectures at national/international congresses.